ScanZ

About This Project

Acne is the number one skincare problem in teenagers, and in western societies it is nearly universal, afflicting 79% to 95% of the adolescent population. It is a highly emotional issue and carries social stigma for many. In men and women older than 25 years, 40% to 54% have some degree of facial acne, and clinical facial acne persists into middle age in 12% of women and 3% of men. Each year in England, 24% of the population see their family doctor for skin disease: in 2009-10 882,000 patients were referred to dermatologists. And waiting lists for doctors are on the increase.


ScanZ is a medically-certified skin imaging point-of-care device for acne diagnosis support available in two forms: a consumer version for patients to perform self-analysis and track their skin health away from the clinic, and a premium version for use by healthcare professionals to speed up assessment and support diagnosis.


The easy-to-use handheld device connects to the user’s smart device, enabling instant viewing and real-time info sharing between patient and doctor. ScanZ is able to take measurements and understand what is happening under the skin. It is self-learning and gets to know the user over time, improving its recommendations and predictions the more it is used. The device also remotely connects with data servers to create a large catalogue of clinical traces, enabling big data analytics of acne.

ScanZ saves patients time by removing the need for follow up visits while receiving the same service, and doctors can concentrate on patients with more severe problems and reduce waiting list times.

Topic
PHC-12 - Clinical research for the validation of biomarkers and/or diagnostic medical devices
Year

2014

Cutoff

September

Beneficiaries

Coordinator

mySkin d.o.o.

Country

Serbia